248 related articles for article (PubMed ID: 24027286)
1. Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.
Akerman S; Holland PR; Lasalandra MP; Goadsby PJ
J Neurosci; 2013 Sep; 33(37):14869-77. PubMed ID: 24027286
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons.
Akerman S; Holland PR; Goadsby PJ
J Pharmacol Exp Ther; 2007 Jan; 320(1):64-71. PubMed ID: 17018694
[TBL] [Abstract][Full Text] [Related]
3. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception.
Bartsch T; Knight YE; Goadsby PJ
Ann Neurol; 2004 Sep; 56(3):371-81. PubMed ID: 15349864
[TBL] [Abstract][Full Text] [Related]
4. Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons.
Pozo-Rosich P; Storer RJ; Charbit AR; Goadsby PJ
Cephalalgia; 2015 Dec; 35(14):1298-307. PubMed ID: 25792688
[TBL] [Abstract][Full Text] [Related]
5. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.
Liao HT; Lee HJ; Ho YC; Chiou LC
Br J Pharmacol; 2011 May; 163(2):330-45. PubMed ID: 21232043
[TBL] [Abstract][Full Text] [Related]
6. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
7. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
Rea K; Ford GK; Olango WM; Harhen B; Roche M; Finn DP
Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683
[TBL] [Abstract][Full Text] [Related]
8. Endovanilloids are potential activators of the trigeminovascular nocisensor complex.
Dux M; Deák É; Tassi N; Sántha P; Jancsó G
J Headache Pain; 2016; 17():53. PubMed ID: 27189587
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
Batista PA; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
[TBL] [Abstract][Full Text] [Related]
10. Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA.
Tjen-A-Looi SC; Li P; Longhurst JC
J Appl Physiol (1985); 2009 Jun; 106(6):1793-9. PubMed ID: 19325030
[TBL] [Abstract][Full Text] [Related]
11. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
[TBL] [Abstract][Full Text] [Related]
12. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat.
Dean C
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R771-9. PubMed ID: 21228344
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
15. Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo.
Kelly S; Chapman V
J Neurophysiol; 2001 Dec; 86(6):3061-4. PubMed ID: 11731561
[TBL] [Abstract][Full Text] [Related]
16. Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats.
Escobar W; Ramirez K; Avila C; Limongi R; Vanegas H; Vazquez E
Eur J Pain; 2012 May; 16(5):676-89. PubMed ID: 22337336
[TBL] [Abstract][Full Text] [Related]
17. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray.
Lisboa SF; Camargo LH; Magesto AC; Resstel LB; Guimarães FS
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1193-206. PubMed ID: 24438603
[TBL] [Abstract][Full Text] [Related]
19. Periaqueductal Grey EP3 Receptors Facilitate Spinal Nociception in Arthritic Secondary Hypersensitivity.
Drake RA; Leith JL; Almahasneh F; Martindale J; Wilson AW; Lumb B; Donaldson LF
J Neurosci; 2016 Aug; 36(35):9026-40. PubMed ID: 27581447
[TBL] [Abstract][Full Text] [Related]
20. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
